Reframing Thyroid Cancer: Precision, Progress & Personalized Care
No se pudo agregar al carrito
Add to Cart failed.
Error al Agregar a Lista de Deseos.
Error al eliminar de la lista de deseos.
Error al añadir a tu biblioteca
Error al seguir el podcast
Error al dejar de seguir el podcast
Reframing Thyroid Cancer: Precision, Progress & Personalized Care
-
Narrado por:
-
De:
Why do thyroid cancers demand a more nuanced approach, despite high survival rates?
In this episode of Doc to Doc, Dr. Meghan Crawley, head and neck surgical oncologist at Miami Cancer Institute, joins Dr. Rachel Slotcavage, endocrine surgeon at Lynn Cancer Institute, to explore what makes thyroid cancers so unique and how treatment approaches are evolving.
From surgery and RAI therapy to targeted therapies, immunotherapy, and biomarker-driven decisions, this conversation takes a closer look at how precision medicine is shaping the future of thyroid cancer care—and what every clinician should consider in today’s multidisciplinary landscape.
Meghan Crawley, M.D.
Head and Neck Surgical Oncologist with Baptist Health Miami Cancer Institute
Rachel Slotcavage, M.D.
Endocrine surgeon with the Eugene M. & Christine E. Lynn Cancer Institute, part of Baptist Health, at Boca Raton Regional Hospital